Approval · Notice of Compliance 35815 · 2025
ELTROXIN: Notice of Compliance 35815
Issued July 31, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35815
- Date
- July 31, 2025
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of new strength: 25mcg, 75mcg, 88mcg, 112mcg, 125mcg, 137mcg, and 175mcg Tablets
Products in this notice
Medicinal ingredients
- LEVOTHYROXINE SODIUM 50 MCG per TAB
- LEVOTHYROXINE SODIUM 100 MCG per TAB
- LEVOTHYROXINE SODIUM 150 MCG per TAB
- LEVOTHYROXINE SODIUM 200 MCG per TAB
- LEVOTHYROXINE SODIUM 25 MCG per TAB
- LEVOTHYROXINE SODIUM 75 MCG per TAB
- LEVOTHYROXINE SODIUM 88 MCG per TAB
- LEVOTHYROXINE SODIUM 112 MCG per TAB
- LEVOTHYROXINE SODIUM 125 MCG per TAB
- LEVOTHYROXINE SODIUM 137 MCG per TAB
- LEVOTHYROXINE SODIUM 175 MCG per TAB